Intercept Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:ICPT)

Earnings

Intercept Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, February 25th, 2020. Intercept Pharmaceuticals will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Intercept Pharmaceuticals Earnings Estimates and Actuals by Quarter

Intercept Pharmaceuticals (NASDAQ:ICPT) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	4	($2.91)	($2.24)	($2.62)
Q2 2020	4	($2.97)	($1.96)	($2.35)
Q3 2020	4	($2.54)	($1.61)	($2.16)
Q4 2020	4	($2.58)	($0.56)	($1.56)

Intercept Pharmaceuticals (NASDAQ ICPT) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call	Details
2/25/2020 (Confirmed)		($2.52)					Register (Before Market Opens)
11/5/2019	Q3 2019	($2.35)	($2.59)	($2.59)	$63.89 million	$61.95 million	Transcript
8/7/2019	Q2 2019	($2.51)	($2.28)	($2.28)	$58.78 million	$66.30 million	Listen
5/8/2019	3/31/2019	($2.57)	($3.03)	($3.03)	$52.15 million	$52.25 million	Listen
2/28/2019	Q4 2018	($2.42)	($2.97)	($2.97)	$52.53 million	$53.30 million	N/A
10/31/2018	9/30/2018	($2.65)	($2.18)	($2.18)	$48.24 million	$47.00 million	N/A
8/2/2018	Q2 2018	($2.83)	($2.58)	($2.58)	$41.26 million	$43.58 million	N/A
5/8/2018	Q1 2018	($3.41)	($3.22)	($3.22)	$38.44 million	$35.96 million	N/A
2/14/2018	Q4 2017	($3.39)	($4.43)	($4.43)	$39.01 million	$37.69 million	N/A
11/1/2017	Q3 2017	($3.48)	($2.89)	($2.89)	$36.95 million	$41.33 million	N/A
7/31/2017	Q2 2017	($3.62)	($3.46)	($3.46)	$27.50 million	$30.89 million	N/A
5/4/2017	Q1 2017	($4.27)	($3.61)	($3.61)	$15.88 million	$21.00 million	Listen
2/23/2017	Q416	($3.74)	($4.84)	($4.84)	$8.96 million	$13.00 million	N/A
11/3/2016	Q316	($3.82)	($3.59)	($3.59)	$4.77 million	$4.70 million	N/A
8/4/2016	Q216	($3.69)	($3.14)	($3.14)	$1.72 million	$5.52 million	N/A
5/5/2016	Q1	($3.60)	($3.33)	($1.49)	$0.49 million	$0.45 million	N/A
2/23/2016	Q415	($3.15)	($3.62)	($3.62)	$0.43 million	$0.45 million	Listen
11/9/2015	Q315	($2.74)	($2.10)	($2.10)	$0.42 million	$0.45 million	N/A
8/5/2015	Q215	($1.95)	($1.99)	($1.99)	$2.17 million	$0.45 million	N/A
5/11/2015	Q115	($1.75)	($1.78)	($1.78)	$1.70 million	$1.70 million	Listen
3/2/2015	Q414	($1.53)	($1.63)	($1.63)	$0.42 million	$0.04 million	N/A
11/6/2014	Q3	($1.10)	($1.69)	($1.69)	$0.46 million	$0.45 million	N/A
8/11/2014	Q214	($1.10)	$1.51	$1.51	$400.00 million	$405.40 million	N/A
5/7/2014	Q1 2014	($0.72)	($1.59)	$10.03	$0.41 million	$0.41 million	N/A
3/14/2014	Q4 2013	($0.60)	($0.72)	($0.80)	$0.41 million	$0.41 million	N/A
11/14/2013	Q3 2013	($0.57)	($0.64)	$0.37	$0.89 million	$0.41 million	N/A
8/13/2013	Q2 2013	($0.52)	($0.79)	($0.79)	$0.40 million	$0.41 million	N/A
5/14/2013	Q1 2013	($0.44)	($0.62)	($0.62)	$1.23 million	$0.41 million	N/A
3/18/2013	Q4 2012	($0.37)	($0.43)	$1.16			N/A
11/26/2012	Q3 2012	($0.57)	($1.86)	($1.86)			N/A

(Earnings results data provided by Zacks Investment Research)